<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Pharmacodynamics - Essentials of Medical Pharmacology</title>

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>

code
Code
download
content_copy
expand_less
<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->
<nav class="floating-toc" id="floating-toc">
    <div class="floating-toc-header">
        <span>üìë</span> Table of Contents
    </div>
    <ul class="floating-toc-list">
        <li><a href="#principles">Principles of Drug Action</a></li>
        <li><a href="#mechanisms">Mechanisms of Action</a></li>
        <li><a href="#enzymes">Enzymes</a></li>
        <li><a href="#ion-channels">Ion Channels & Transporters</a></li>
        <li><a href="#receptors">Receptors</a></li>
        <li><a href="#transducers">Transducer Mechanisms</a></li>
        <li><a href="#dose-response">Dose-Response Relationship</a></li>
        <li><a href="#interactions">Synergism & Antagonism</a></li>
        <li><a href="#problem-study">Problem Directed Study</a></li>
    </ul>
</nav>

<div class="page-wrapper">
    <div class="container">
        <article class="document-article">
            <header class="document-header">
                <div class="header-badge">
                    <span>‚öôÔ∏è</span>
                    <span>Topic 04</span>
                </div>
                <h1 class="document-title">Pharmacodynamics: Mechanism of Drug Action; Receptor Pharmacology</h1>
                <div class="title-meta">
                    <div class="meta-item">
                        <span>üìö</span>
                        <span>General Pharmacological Principles</span>
                    </div>
                    <div class="meta-item">
                        <span>‚è±Ô∏è</span>
                        <span>45 min read</span>
                    </div>
                </div>
            </header>

            <main id="main-content" class="content-wrapper">
                <!-- Section 1: Principles -->
                <section class="content-section" id="principles">
                    <div class="section-header">
                        <div class="section-number">01</div>
                        <h2 class="section-title">
                            <span class="title-icon">‚ö°</span>
                            Principles of Drug Action
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Pharmacodynamics is the study of drug effects. It attempts to elucidate the complete action-effect sequence and the dose-effect relationship. Drugs do not impart new functions to any system, organ or cell; they only alter the pace of ongoing activity.</p>
                        
                        <div class="grid grid-3">
                            <div class="grid-item">
                                <h4>1. Stimulation</h4>
                                <p>Selective enhancement of the level of activity of specialized cells (e.g., adrenaline stimulates heart). Excessive stimulation is often followed by depression.</p>
                            </div>
                            <div class="grid-item">
                                <h4>2. Depression</h4>
                                <p>Selective diminution of activity of specialized cells (e.g., barbiturates depress CNS, quinidine depresses heart).</p>
                            </div>
                            <div class="grid-item">
                                <h4>3. Irritation</h4>
                                <p>Nonselective, noxious effect on less specialized cells (epithelium, connective tissue). Can result in inflammation, corrosion, necrosis.</p>
                            </div>
                            <div class="grid-item">
                                <h4>4. Replacement</h4>
                                <p>Use of natural metabolites, hormones or their congeners in deficiency states (e.g., insulin in diabetes, iron in anaemia).</p>
                            </div>
                            <div class="grid-item">
                                <h4>5. Cytotoxic action</h4>
                                <p>Selective action on invading parasites or cancer cells without significantly affecting host cells (e.g., penicillin, chloroquine).</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 2: Mechanisms -->
                <section class="content-section" id="mechanisms">
                    <div class="section-header">
                        <div class="section-number">02</div>
                        <h2 class="section-title">
                            <span class="title-icon">üîë</span>
                            Mechanism of Drug Action
                        </h2>
                    </div>

                    <div class="content-card">
                        <h3>Physical & Chemical Mechanisms</h3>
                        <p>Only a handful of drugs act by virtue of their simple physical or chemical property.</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker"></span> <strong>Physical mass:</strong> Bulk laxatives (ispaghula).</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Adsorptive property:</strong> Activated charcoal.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Osmotic activity:</strong> Mannitol, mag. sulfate.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Chemical neutralization:</strong> Antacids.</li>
                            <li class="list-item"><span class="list-marker"></span> <strong>Chelation:</strong> EDTA, dimercaprol.</li>
                        </ul>

                        <h3>Target Biomolecules</h3>
                        <p>Majority of drugs produce their effects by interacting with discrete target biomolecules, usually proteins. These can be grouped into four major categories:</p>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-f1982f6e.jpeg" alt="Four major types of biomacromolecular targets of drug action" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.1: Four major types of biomacromolecular targets. (A) Enzyme; (B) Transmembrane ion channel; (C) Membrane bound transporter; (D) Receptor.</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Section 3: Enzymes -->
                <section class="content-section" id="enzymes">
                    <div class="section-header">
                        <div class="section-number">03</div>
                        <h2 class="section-title">
                            <span class="title-icon">üèóÔ∏è</span>
                            Enzymes as Targets
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Drugs can either increase (stimulation) or decrease (inhibition) the rate of enzymatically mediated reactions.</p>
                        
                        <h4>Enzyme Inhibition</h4>
                        <p>Selective inhibition is a common mode of drug action.</p>
                        
                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Type</th>
                                        <th>Mechanism</th>
                                        <th>Kinetics</th>
                                        <th>Examples</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Competitive</strong><br>(Equilibrium)</td>
                                        <td>Drug competes with substrate for catalytic site.</td>
                                        <td>$K_m$ increases<br>$V_{max}$ unchanged</td>
                                        <td>Physostigmine (Cholinesterase)<br>Sulfonamides (Folate synthase)<br>Captopril (ACE)</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Noncompetitive</strong></td>
                                        <td>Inhibitor binds to adjacent site, altering enzyme function.</td>
                                        <td>$K_m$ unchanged<br>$V_{max}$ reduced</td>
                                        <td>Acetazolamide (Carbonic anhydrase)<br>Aspirin (Cyclooxygenase)<br>Theophylline (Phosphodiesterase)</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-c39818f7.jpeg" alt="Kinetics of enzyme reaction" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.2: Effect of enzyme induction, stimulation and inhibition on kinetics of enzyme reaction.</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Section 4: Ion Channels & Transporters -->
                <section class="content-section" id="ion-channels">
                    <div class="section-header">
                        <div class="section-number">04</div>
                        <h2 class="section-title">
                            <span class="title-icon">üîã</span>
                            Ion Channels & Transporters
                        </h2>
                    </div>

                    <div class="content-card">
                        <h3>Ion Channels</h3>
                        <p>Proteins acting as ion selective channels participate in transmembrane signaling. Drugs can affect them directly or indirectly.</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Direct physical block:</strong> Local anaesthetics block voltage sensitive Na<sup>+</sup> channels.</li>
                            <li class="list-item"><strong>Modulators:</strong>
                                <ul>
                                    <li><strong>Quinidine:</strong> Blocks myocardial Na<sup>+</sup> channels.</li>
                                    <li><strong>Nifedipine:</strong> Blocks L-type voltage sensitive Ca<sup>2+</sup> channels.</li>
                                    <li><strong>Sulfonylureas:</strong> Inhibit ATP-sensitive K<sup>+</sup> channels in pancreatic $\beta$ cells.</li>
                                    <li><strong>Nicorandil:</strong> Opens ATP-sensitive K<sup>+</sup> channels.</li>
                                </ul>
                            </li>
                        </ul>

                        <h3>Transporters</h3>
                        <p>Drugs interact with solute carrier (SLC) transporters to inhibit ongoing physiological transport.</p>
                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>Examples</h4>
                                <ul>
                                    <li><strong>Desipramine/Cocaine:</strong> Block Norepinephrine Transporter (NET).</li>
                                    <li><strong>Fluoxetine (SSRIs):</strong> Inhibits Serotonin Transporter (SERT).</li>
                                    <li><strong>Furosemide:</strong> Inhibits Na<sup>+</sup>K<sup>+</sup>2Cl<sup>-</sup> cotransporter.</li>
                                    <li><strong>Probenecid:</strong> Inhibits Organic Anion Transporter (OAT).</li>
                                </ul>
                            </div>
                            <div class="grid-item">
                                <h4>Mechanism</h4>
                                <p>Interaction interferes with the translocation of the substrate (metabolite/ion) across the membrane, often resulting in accumulation of the substrate on one side.</p>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 5: Receptors -->
                <section class="content-section" id="receptors">
                    <div class="section-header">
                        <div class="section-number">05</div>
                        <h2 class="section-title">
                            <span class="title-icon">üì°</span>
                            Receptors
                        </h2>
                    </div>

                    <div class="content-card">
                        <p><strong>Receptor:</strong> A macromolecule or binding site located on the surface or inside the effector cell that serves to recognize the signal molecule/drug and initiate the response to it, but itself has no other function.</p>

                        <h3>Terminology</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Agonist:</strong> Activates a receptor to produce an effect similar to physiological signal. (Affinity + Maximal Intrinsic Activity = 1)</li>
                            <li class="list-item"><strong>Antagonist:</strong> Prevents action of agonist but has no effect of its own. (Affinity + Zero Intrinsic Activity = 0)</li>
                            <li class="list-item"><strong>Partial Agonist:</strong> Activates receptor to produce submaximal effect but antagonizes full agonist. (Affinity + Submaximal Intrinsic Activity between 0 and 1)</li>
                            <li class="list-item"><strong>Inverse Agonist:</strong> Activates receptor to produce effect in opposite direction to agonist. (Affinity + Negative Intrinsic Activity between 0 and -1)</li>
                        </ul>

                        <h3>Receptor Occupation Theory</h3>
                        <p>Clark (1937) proposed that drug effect is a direct function of drug-receptor complexes formed.</p>
                        <div class="equation">
                            $$D + R \rightleftarrows DR \rightarrow E$$
                        </div>

                        <h3>Two-State Receptor Model</h3>
                        <p>Receptors exist in equilibrium between Active ($Ra$) and Inactive ($Ri$) states.</p>
                        <ul>
                            <li><strong>Agonist:</strong> Binds preferentially to $Ra$, shifting equilibrium to active state.</li>
                            <li><strong>Antagonist:</strong> Binds equally to $Ra$ and $Ri$, maintaining equilibrium (no response, blocks agonist).</li>
                            <li><strong>Partial Agonist:</strong> Slightly greater affinity for $Ra$.</li>
                            <li><strong>Inverse Agonist:</strong> Binds preferentially to $Ri$, stabilizing inactive state (reduces constitutive activation).</li>
                        </ul>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-6df96621.jpeg" alt="Two-state receptor model" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.3: Illustration of the two-state receptor model.</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Section 6: Transducer Mechanisms -->
                <section class="content-section" id="transducers">
                    <div class="section-header">
                        <div class="section-number">06</div>
                        <h2 class="section-title">
                            <span class="title-icon">üîÑ</span>
                            Transducer Mechanisms
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Receptor-effector linkage mechanisms can be grouped into 5 major categories.</p>

                        <h4>1. G-Protein Coupled Receptors (GPCRs)</h4>
                        <p>Large family of 7-transmembrane helix receptors linked to effectors via G-proteins (Gs, Gi, Go, Gq).</p>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-7e096f27.jpeg" alt="G-protein coupled receptor molecule" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.5: Structure of G-protein coupled receptor.</figcaption>
                        </figure>

                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Pathway</th>
                                        <th>Mediators</th>
                                        <th>Examples</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Adenylyl Cyclase: cAMP</strong></td>
                                        <td>Gs $\uparrow$ cAMP<br>Gi $\downarrow$ cAMP</td>
                                        <td>$\beta$-adrenergic (Gs)<br>$\alpha_2$-adrenergic (Gi)<br>Muscarinic M2 (Gi)</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Phospholipase C: IP3/DAG</strong></td>
                                        <td>Gq $\rightarrow$ IP3 (release Ca<sup>2+</sup>) + DAG (activate PKC)</td>
                                        <td>$\alpha_1$-adrenergic<br>Muscarinic M1, M3<br>5-HT2</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Channel Regulation</strong></td>
                                        <td>Gs, Gi, Go $\rightarrow$ Open/Close Ca<sup>2+</sup>/K<sup>+</sup> channels</td>
                                        <td>Cardiac Ca<sup>2+</sup> channels (Gs)<br>K<sup>+</sup> channels (Gi)</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h4>2. Ion Channel Receptors</h4>
                        <p>Ligand gated ion channels (fastest response, milliseconds). Example: Nicotinic cholinergic, GABA<sub>A</sub>, 5-HT<sub>3</sub>.</p>

                        <h4>3. Transmembrane Enzyme-Linked Receptors</h4>
                        <p>Intracellular domain has enzymatic activity (e.g., Tyrosine Kinase). Example: Insulin, EGF, ANP.</p>

                        <h4>4. JAK-STAT Binding Receptors</h4>
                        <p>Receptor has no intrinsic activity but binds Janus Kinase (JAK) $\rightarrow$ phosphorylates STAT $\rightarrow$ gene transcription. Example: Cytokines, Growth hormone.</p>

                        <h4>5. Nuclear Receptors</h4>
                        <p>Intracellular receptors regulating gene expression (slowest response, hours). Example: Steroids, Thyroxine, Vit D.</p>
                    </div>
                </section>

                <!-- Section 7: Dose-Response -->
                <section class="content-section" id="dose-response">
                    <div class="section-header">
                        <div class="section-number">07</div>
                        <h2 class="section-title">
                            <span class="title-icon">üìâ</span>
                            Dose-Response Relationship
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>The relationship between dose and response is described by a rectangular hyperbola, which becomes a sigmoid curve when dose is plotted on a log scale.</p>
                        
                        <div class="equation">
                            $$E = \frac{E_{max} \times [D]}{K_D + [D]}$$
                        </div>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-6d8fa740.jpeg" alt="Drug potency and efficacy curves" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.13: Illustration of drug potency and efficacy.</figcaption>
                        </figure>

                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>Potency</h4>
                                <p>Position on the dose axis. Amount of drug needed to produce a certain response. Relative potency compares $EC_{50}$.</p>
                            </div>
                            <div class="grid-item">
                                <h4>Efficacy</h4>
                                <p>The maximal response ($E_{max}$) that can be elicited by the drug. Efficacy is often more decisive than potency in clinical choice.</p>
                            </div>
                        </div>
                        
                        <p><strong>Therapeutic Index:</strong> Gap between therapeutic effect and adverse effect curves. $\text{TI} = \frac{LD_{50}}{ED_{50}}$.</p>
                    </div>
                </section>

                <!-- Section 8: Interactions -->
                <section class="content-section" id="interactions">
                    <div class="section-header">
                        <div class="section-number">08</div>
                        <h2 class="section-title">
                            <span class="title-icon">ü§ù</span>
                            Synergism & Antagonism
                        </h2>
                    </div>

                    <div class="content-card">
                        <h3>Synergism</h3>
                        <p>Action of one drug is facilitated by the other.</p>
                        <ul>
                            <li><strong>Additive:</strong> Effect of A + B = Effect of A + Effect of B (e.g., Aspirin + Paracetamol).</li>
                            <li><strong>Supraadditive (Potentiation):</strong> Effect of A + B > Effect of A + Effect of B (e.g., Levodopa + Carbidopa).</li>
                        </ul>

                        <h3>Antagonism</h3>
                        <p>One drug decreases the action of another.</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Physical:</strong> Charcoal adsorbs alkaloids.</li>
                            <li class="list-item"><strong>Chemical:</strong> KMnO4 oxidizes alkaloids.</li>
                            <li class="list-item"><strong>Physiological:</strong> Drugs act on different receptors with opposite effects (Histamine vs Adrenaline).</li>
                            <li class="list-item"><strong>Receptor Antagonism:</strong>
                                <ul>
                                    <li><strong>Competitive (Equilibrium):</strong> Antagonist binds to same site. Parallel shift of DRC to right. Surmountable by increasing agonist concentration. (ACh vs Atropine).</li>
                                    <li><strong>Noncompetitive:</strong> Antagonist binds to different site or interferes with downstream mechanism. DRC flattened, $E_{max}$ reduced. Unsurmountable. (Diazepam vs Bicuculline).</li>
                                    <li><strong>Nonequilibrium:</strong> Covalent binding. Irreversible. (Phenoxybenzamine).</li>
                                </ul>
                            </li>
                        </ul>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-74a03d95.jpeg" alt="Competitive and noncompetitive antagonism curves" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 4.19: Dose-response curves showing competitive (a) and noncompetitive (b) antagonism.</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Problem Directed Study -->
                <section class="content-section" id="problem-study">
                    <div class="section-header">
                        <div class="section-number">09</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß©</span>
                            Problem Directed Study
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="callout callout--warning">
                            <div class="callout-header">
                                <span class="callout-icon">‚ùì</span>
                                <h4 class="callout-title">Case Study 4.1</h4>
                            </div>
                            <div class="callout-content">
                                <p>A patient being treated with methotrexate (Mtx) developed oral ulceration, megaloblastic anaemia and other toxic symptoms. Given that (i) Mtx acts by inhibiting the enzyme dihydrofolate reductase (DHFRase) which generates the essential coenzyme tetrahydrofolic acid (THFA) from dihydrofolic acid (DHFA) needed for one carbon transfer reactions, (ii) Mtx binds to the catalytic site of DHFRase with an affinity 50,000 times greater than the natural substrate DHFA, and that (iii) two forms of folate viz. folic acid and folinic acid (N5 formyl THFA) are available for therapeutic use:</p>
                                <p><strong>(a) Which type of enzyme inhibition will be produced by Mtx?</strong><br>
                                <strong>(b) Which form of folate should be used to treat Mtx toxicity?</strong></p>
                                <p><em>(See Appendix-1 for solution)</em></p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <nav class="document-nav">
                <div class="nav-container">
                    <a href="topic-03-pharmacokinetics-metabolism.html" class="nav-button nav-button--large nav-button--previous">
                        <div class="nav-label">Previous</div>
                        <div class="nav-title">Metabolism & Excretion</div>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span>4</span>
                            <span class="progress-separator">/</span>
                            <span>13</span>
                        </div>
                        <div class="progress-bar-container">
                            <div class="progress-bar-fill" style="width: 30.7%;"></div>
                        </div>
                        <div class="progress-label">Topic Progress</div>
                    </div>
                    
                    <a href="topic-05-pharmacotherapy.html" class="nav-button nav-button--large nav-button--next">
                        <div class="nav-label">Next</div>
                        <div class="nav-title">Aspects of Pharmacotherapy</div>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<!-- Lightbox Modal -->
<div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
    <div class="lightbox-backdrop"></div>
    <div class="lightbox-content">
        <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
        <img class="lightbox-image" src="" alt="">
        <p class="lightbox-caption"></p>
    </div>
</div>

<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>
</body>
</html>
